SelectQuote, Inc. (NYSE:SLQT – Get Free Report) CEO Timothy Danker acquired 100,668 shares of SelectQuote stock in a transaction that occurred on Friday, November 6th. The shares were purchased at an average cost of $0.50 per share, with a total value of $50,334.00. Following the completion of the acquisition, the chief executive officer owned 3,076,073 shares of the company’s stock, valued at $1,538,036.50. The trade was a 3.38% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
SelectQuote Stock Up 2.6%
SLQT opened at $0.46 on Wednesday. The company has a debt-to-equity ratio of 1.16, a quick ratio of 7.48 and a current ratio of 7.48. The company has a market cap of $82.36 million, a price-to-earnings ratio of 44.73 and a beta of 2.01. SelectQuote, Inc. has a one year low of $0.30 and a one year high of $1.76. The business’s fifty day moving average is $0.42 and its two-hundred day moving average is $0.75.
SelectQuote (NYSE:SLQT – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.33) by $0.12. SelectQuote had a return on equity of 22.48% and a net margin of 4.61%. The business had revenue of $280.01 million during the quarter, compared to the consensus estimate of $277.91 million. Analysts anticipate that SelectQuote, Inc. will post -0.25 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research analysts have recently weighed in on the stock. Wall Street Zen cut shares of SelectQuote from a “hold” rating to a “sell” rating in a research note on Saturday, August 29th. Zacks Research upgraded SelectQuote from a “strong sell” rating to a “hold” rating in a research report on Monday, October 26th. Finally, Weiss Ratings cut SelectQuote from a “sell (d+)” rating to a “sell (d)” rating in a research report on Monday, August 17th. One research analyst has rated the stock with a Strong Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $3.00.
Read Our Latest Stock Analysis on SelectQuote
Institutional Trading of SelectQuote
A number of hedge funds have recently bought and sold shares of the company. BlackRock Inc. acquired a new position in SelectQuote in the 2nd quarter valued at $1,836,000. GSA Capital Partners LLP purchased a new stake in shares of SelectQuote in the second quarter valued at $1,123,000. Renaissance Technologies LLC grew its position in shares of SelectQuote by 817.6% in the first quarter. Renaissance Technologies LLC now owns 1,021,239 shares of the company’s stock valued at $643,000 after purchasing an additional 909,939 shares during the period. Squarepoint Ops LLC acquired a new position in SelectQuote in the second quarter valued at $536,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in SelectQuote in the second quarter valued at $461,000. Institutional investors and hedge funds own 34.59% of the company’s stock.
SelectQuote News Roundup
Here are the key news stories impacting SelectQuote this week:
- Positive Sentiment: Executives and directors bought a combined 919,905 shares for about $447,000 in transactions on November 6 and 9. Purchasers included the CEO, president, COO, and two directors; the largest reported purchase was 409,836 shares by Director Raymond F. Weldon. Broad insider buying may signal confidence, though it does not guarantee improved results. SEC filing SEC filing
- Neutral Sentiment: A report says SelectQuote placed fewer Medicare policies but earned more on each one. Higher per-policy earnings may partly offset weaker policy volume, but the article details provided do not establish the overall effect on revenue or profit. SelectQuote places fewer Medicare policies but earns more on each one
SelectQuote Company Profile
SelectQuote, Inc. (NYSE: SLQT) operates a technology-enabled insurance distribution platform that helps consumers compare and purchase insurance products from third-party carriers. The company combines digital tools, proprietary data and licensed agents to connect customers with coverage suited to their needs. SelectQuote’s primary business is its Senior segment, which provides access to Medicare Advantage, Medicare Supplement and prescription drug plans. The company has also historically offered life insurance, as well as auto and home insurance, through its Life and Auto & Home businesses.
Read More
- Five stocks we like better than SelectQuote
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.
